![Paolo Bassanini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paolo Bassanini
Nessuna posizione attualmente
Profilo
Mr. Paolo Bassanini is Investor Relations Officer at THERAMetrics holding AG.
Mr. Bassanini was previously employed as Manager-Business Development & Investor Relations by Molecular Medicine SpA.
Precedenti posizioni note di Paolo Bassanini
Società | Posizione | Fine |
---|---|---|
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Contatto Relazioni con gli Investitori | 01/09/2013 |
MOLMED S.P.A. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | Health Technology |
AGC Biologics SpA
![]() AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
- Borsa valori
- Insiders
- Paolo Bassanini